Anal Cancer

This book is a comprehensive overview of the epidemiology, pathogenesis, and treatment options available for anal cancer. Anal cancer is a relatively rare disease, but one increasing in incidence. Strides have been made in developing treatment paradigms through clinical trials, and proper management requires multidisciplinary interaction between radiation oncologists, surgeons, and medical oncologists as well as other physicians, nurses, and other medical professionals.  The book thus covers all aspects of the disease to give clinicians and their teams the information necessary to develop a treatment program that focuses on improved patient outcomes. Chapters cover evaluation of the patient and cancer staging, current standard treatments, epidemiology, pathogenesis, issues involved in survivorship, and ongoing and future avenues of research into disease biology and novel treatments. This book is an ideal resource for clinicians involved in the care of patients with anal cancer.

Jeffrey Meyer, MD, MS

Johns Hopkins University School of Medicine

Department of Radiation Oncology and Molecular Radiation Sciences

Baltimore, MD, USA

 

Lisa Kachnic, MD, FASTRO

Professor and Chair of Radiation Oncology

Vanderbilt University Medical Center

Department of Radiation Oncology

Nashville, TN, USA